HCPCS Code J0210: Methyldopate HCl billing and reimbursement guide

Key takeaways

HCPCS Code J0210 covers an injection of methyldopate hydrochloride (HCl), up to 250 mg, given intravenously.

Medicare Part B covers J0210 when the drug is medically necessary, and pays it on quarterly ASP-based pricing.

One billing unit equals up to 250 mg, so divide the total dose by 250 mg and round up.

Methyldopate HCl is labeled for intravenous use only, so pair it with 96374 for an IV push, never 96372.

Every claim needs the 11-digit National Drug Code (NDC) for the product used, plus a supporting ICD-10-CM diagnosis.

HCPCS Code J0210 is the billing code for an injection of methyldopate hydrochloride, up to 250 mg. It sits in the Level II J-series, which covers drugs given by a route other than oral. One unit on the claim line represents up to 250 mg administered.

This guide covers the code definition, Medicare coverage rules, ASP-based payment, the NDC crosswalk, ICD-10 pairing, and a step-by-step billing workflow. It also breaks down the four denial patterns that send J0210 claims back, including the administration code that never belongs on this claim.

HCPCS Code J0210: Definition and code details

IV therapy practices and outpatient billing teams use J0210 to report an injection of methyldopate hydrochloride, up to 250 mg. The Centers for Medicare and Medicaid Services, known as CMS, maintains the code. It is active, sits at HCPCS Level II, and belongs to the J-series for drugs given by routes other than oral.

J-codes sit inside HCPCS Level II, which CMS uses for drugs, biologicals, supplies, and services that CPT does not cover. The J-series captures physician-administered drugs. That makes J0210 the right code whenever methyldopate HCl is injected rather than swallowed.

Methyldopate HCl: Drug overview and clinical context

Methyldopate hydrochloride is the injectable salt form of methyldopa, a centrally acting antihypertensive. It reduces sympathetic outflow from the central nervous system, which lowers peripheral vascular resistance and blood pressure.

Practices reach for it when oral antihypertensives work too slowly, or when the patient cannot take anything by mouth.

Contemporary use is limited, and newer antihypertensives have replaced it in most protocols. The injectable formulation is still available, and the HCPCS code is still active.

OB-GYN practices are among the settings that still use it, since methyldopa has a long safety record in hypertensive disorders of pregnancy.

J0210 fee schedule and Medicare reimbursement rates

Medicare Part B pays J0210 using the average sales price (ASP) methodology. CMS publishes an updated ASP drug pricing file every quarter.

The national payment amount reflects ASP plus a statutory add-on percentage set under the Medicare Modernization Act. Rates move each quarter, so check the current figure on the Physician Fee Schedule lookup before you quote a number.

Individual Medicare Administrative Contractors (MACs) may apply locality adjustments. The national payment amount is a baseline rather than a guaranteed rate. Facilities in high-cost metropolitan areas may see slightly more than the national figure.

Medicare Part B coverage rules

Medicare Part B covers physician-administered drugs, including injectable antihypertensives like methyldopate HCl, when the patient cannot self-administer them. Coverage also depends on medical necessity documentation. A claim without a supporting diagnosis is denied, even when the drug was clearly given.

J0210 fits the buy-and-bill model. The practice buys the drug, administers it in the office, then bills the payer for the drug plus the administration fee. Mobile IV therapy operations and outpatient infusion facilities both work this way. The administration code, usually 96374 for an IV push, is billed alongside J0210 rather than in place of it.

• Coverage requirement: The patient cannot self-administer the drug
• Medical necessity: Clinical documentation must support the diagnosis
• Setting: Physician office, outpatient hospital, or outpatient infusion facility
• Accompanying code: Bill 96374 for an IV push separately from J0210. Use an IV infusion code such as 96365 when the diluted dose runs beyond 15 minutes
• Drug inventory: Keep purchase invoices to document acquisition cost for audit purposes

Methyldopate HCl is labeled for intravenous use only. That rules out 96372, the code for a subcutaneous or intramuscular injection, however the encounter is written up. The dose is usually diluted and infused over 30 to 60 minutes, which points to an infusion code rather than a push.

Practice management software like Pabau records acquisition cost next to the administration note through its drug inventory management tools. You get an audit-ready trail for buy-and-bill compliance without keeping a second spreadsheet.

NDC to HCPCS crosswalk for J0210

Most payers require the National Drug Code (NDC) on the claim line for a drug J-code. The NDC identifies the exact product administered, including manufacturer, package size, and formulation. A missing or invalid NDC is one of the most common reasons J-code claims are rejected.

A small number of suppliers manufacture methyldopate HCl, and NDC numbers vary by manufacturer and package configuration.

Check every mapping against the current CMS NDC crosswalk file rather than a static reference table. Manufacturer changes can invalidate an NDC without notice, so your prescription management tools should store the active NDC with each lot received.

NDC format on claims: Submit the NDC in 11-digit format, using the 5-4-2 labeler-product-package configuration.

Include the unit of measure qualifier, UN for units or ML for milliliters, along with the NDC quantity administered. That quantity is separate from the HCPCS billing units. For programmatic lookups, the Clinical Table Search API returns crosswalk data you can pull into a billing system.

ICD-10 diagnosis codes that support the claim

Every J0210 claim needs an ICD-10-CM diagnosis code that supports medical necessity. The diagnosis tells the payer why the drug was given, and a claim without one fails medical necessity review. IV therapy intake forms help the treating clinician capture that diagnosis in a form that maps straight to billing.

The pairings below reflect the clinical situations where a methyldopate HCl injection is most likely. Check each one against your MAC’s local coverage determination (LCD) before submitting, since accepted diagnosis codes vary by jurisdiction.

Important: Code to the highest level of specificity the clinical documentation supports. A claim coded to I10 when the record describes I16.1 may pass at first, but it creates audit risk. Review your MAC’s LCD for payer-specific restrictions on the diagnosis codes accepted with J0210.

How to bill J0210: Step-by-step coding guide

Three elements have to be right at the same time: the billing unit count, the NDC, and the linked diagnosis. Miss one and the claim fails. Accurate medical billing starts with capturing the dose at the point of care, not reconstructing it later.

1. Confirm the dose administered. Document the exact milligrams of methyldopate HCl given during the encounter. Take the figure from the clinical record, not the vial size.
2. Calculate billing units. Divide the total dose by 250 mg and round up to the nearest whole unit. So 375 mg administered is 2 units. Never round down, since that undercodes the claim.
3. Enter J0210 with the calculated unit count. Each unit on the claim line represents up to 250 mg. Use J0210 as the procedure code.
4. Attach the NDC. Add the 11-digit NDC for the product used, with the unit of measure qualifier and the NDC quantity. Confirm it matches the lot in inventory.
5. Link the ICD-10-CM diagnosis code. Pick the code that matches the indication documented by the treating clinician. Check it is accepted under your MAC’s LCD.
6. Add the drug administration code. Bill 96374 for an IV push, or an infusion code such as 96365 when the diluted dose runs longer than 15 minutes.
7. Check prior authorization status. Confirm whether the payer requires prior authorization before you submit.
8. Submit the claim. Run a pre-submission edit check in your claims management software for a missing NDC, an unsupported diagnosis, or a unit error.

Prior authorization requirements for J0210

Medicare does not require prior authorization, known as PA, for J0210 under the standard Part B drug benefit. Commercial payers and MAC jurisdictions vary widely.

Assuming no PA is needed without checking payer rules is a fast route to a denial. Staff who administer IV therapy should also know which orders trigger a PA workflow at intake.

• Medicare: PA is generally not required under standard Part B coverage, but verify against current MAC policy
• Commercial payers: Requirements vary, so check payer formularies and PA lists before administering
• Medicaid: Requirements differ by state, and some states require PA for injectable antihypertensives off the preferred drug list
• Documentation for PA requests: Include prescriber notes on medical necessity, the diagnosis codes, and the clinical rationale for the IV route
• Prior oral therapy: Add the history where the patient has already tried an oral antihypertensive

When a PA is required, submit the request before the drug is administered. Retroactive authorization is rarely approved, and the practice absorbs the drug cost when it is refused.

Common billing errors to avoid with J0210

Four denial patterns account for most rejected J0210 claims in outpatient drug billing. Each one is visible on the claim before it goes out.

Unit miscalculation

Billing 1 unit for a 500 mg dose is the most common J0210 error. The descriptor reads “up to 250 mg” per unit, so 500 mg is 2 units. Rounding down undercodes the claim. Rounding up when you should not overcodes it and invites an overpayment recovery audit.

Missing or incorrect NDC

Most commercial payers and Medicaid programs reject J-code claims that omit the NDC. The number has to be in 11-digit format with the correct unit qualifier. A 10-digit NDC, or one from a discontinued lot, triggers a denial.

Cross-reference the NDC on file against the AAPC HCPCS reference and the current CMS crosswalk before submission.

Unsupported diagnosis linkage

A diagnosis the payer does not accept as supporting medical necessity produces a medical necessity denial. The usual version is a chronic hypertension code, I10, on a record that describes a hypertensive emergency, I16.1. Code to the highest specificity the documentation supports.

Wrong or missing administration code

J0210 pays for the drug only, and the service of administering it carries a separate CPT code. Submit J0210 on its own and you collect the drug cost without the administration fee. Reverse the mistake, billing only the administration code, and the drug reimbursement goes uncaptured.

The third version of this error is billing 96372 alongside J0210. That code describes a subcutaneous or intramuscular injection, and methyldopate HCl is never given by either route. Use 96374 for an IV push, or 96365 when the diluted dose is infused for longer than 15 minutes.

Related HCPCS J-codes for injectable antihypertensives

Billing staff working with injectable cardiovascular drugs meet the following J-codes alongside or instead of J0210. Knowing the distinctions prevents cross-code errors. An IV therapy EMR that stores the code against each drug in your formulary keeps substitutions off the claim.

The same unit-and-NDC sequence applies to any physician-administered injectable. Teams billing J2597 or J0745 confirm the dose, calculate units, attach the NDC, then link the diagnosis.

Build a code reference library covering every injectable your practice administers, before anyone needs it at the billing desk. Automated inventory tracking keeps it honest by recording which lots are in use, so the NDC on the claim matches the vial on the shelf.

How Pabau keeps J-code claims accurate

Most outpatient teams record the drug in one place and bill it somewhere else. The nurse writes the dose in the chart. The biller then re-keys it into the claim, along with the NDC copied off the vial box. Every hop is a chance to drop a digit.

Pabau closes that hop. The administered dose, the lot, and its NDC sit on the treatment record, and the claim pulls straight from that record. The same holds for every injectable you log, whether that is methyldopate or a routine vaccine on an immunization record form.

Pabau’s medical records management also keeps the administration note, the purchase invoice, and the claim on one patient timeline. When a payer audits a buy-and-bill claim two years later, the acquisition cost and the dose sit together. You answer the request in minutes instead of digging through folders.

Bill J-codes without re-keying the chart

Pabau connects drug administration records to billing claims in one platform. Attach J-codes like J0210, link the ICD-10 diagnosis, and generate a compliant claim without switching systems. See how Pabau handles injectable drug billing for outpatient practices.

Book a demo

Conclusion

J0210 is a low-volume code, which is exactly why it goes wrong. A biller who touches it three times a year builds no muscle memory for the 250 mg unit rule. The same goes for the 11-digit NDC and the IV-only administration code. The fix is a written reference anyone can pull at claim entry.

Build the quick-reference card, refresh it when the quarterly ASP file lands, and check units, NDC, and diagnosis before you submit. That turns a code your team rarely sees into one it can bill without a second look. Book a demo to see how Pabau links drug administration records to clean J-code claims.

Continue your research

Want to see where J-code denials hit your income? Healthcare revenue cycle management maps every step between an administered drug and a paid claim.

Billing a self-pay patient for an injection? Superbill explains which fields a payer needs when the patient submits the claim themselves.

Need the clinical record to hold up in an audit? Nursing documentation covers what to capture at the moment a drug is administered.

Checking who is allowed to give the injection? Who can administer IV therapy outlines scope of practice across clinical roles.

Setting up a new infusion practice? Open an IV therapy clinic walks through licensing, staffing, and billing infrastructure.

Frequently asked questions

More questions on units, NDCs, and coverage